ARTICLE | Company News
ERS Genomics, Knudra deal
November 4, 2016 8:18 PM UTC
ERS Genomics granted Knudra non-exclusive, worldwide rights to IP for CRISPR-Cas9 genome editing for engineering model organisms. Knudra will use the technology to engineer Caenorhabditis elegans and ...
BCIQ Company Profiles
BCIQ Target Profiles